- Cosmetic Surgery
- Critical Care
- Diabetes & Endocrinology
- Diabetes and Endocrinology
- Emergency Medicine
- Family Practice
- HIV & AIDS
- Hematology & Oncology
- Hematology and Oncology
- Infectious Disease
- Internal Medicine
- OBGYN & Women's Health
- OBGYN and Women's Health
- Pain Management
December 2017 Briefing - HIV & AIDS
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for December 2017. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Psychosocial Risk in Teens Tied to Lasting HIV Vulnerability
THURSDAY, Dec. 28, 2017 (HealthDay News) -- High-frequency psychosocial risk factors during adolescence have a lasting effect on the likelihood of engaging in HIV risk behaviors in adulthood, according to a study published online Dec. 12 in AIDS.
Hepatitis B Vaccination Often Missed Among HIV Patients
TUESDAY, Dec. 26, 2017 (HealthDay News) -- More than one-third of adult U.S. HIV patients miss opportunities to initiate hepatitis B vaccination, according to a study published online Dec. 26 in the Annals of Internal Medicine.
CDC: 2015 to 2016 Saw Drop in Life Expectancy in United States
THURSDAY, Dec. 21, 2017 (HealthDay News) -- From 2015 to 2016, life expectancy decreased by one-tenth of a year, and there was an increase in the rate of age-adjusted drug overdose deaths, according to two December data briefs published by the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics.
Primary Care Crucial for Preventing New HIV Infections
TUESDAY, Dec. 19, 2017 (HealthDay News) -- Primary care providers will play an important role in preventing the next wave of HIV infections, according to a report published in Medical Economics.
Male U.S. Doctors Receive Higher Values of Industry Payments
MONDAY, Dec. 18, 2017 (HealthDay News) -- Male physicians in the United States received higher values of general payments from industry than females in 2015, according to a research letter published online Dec. 18 in JAMA Internal Medicine.
Year One Results Out for Value-Based Payment Modifier Program
MONDAY, Dec. 18, 2017 (HealthDay News) -- Almost 30 percent of eligible practices failed to register and report data in the first year of the Physician Value-Based Payment Modifier program, according to a report published in the December issue of Health Affairs.
Doctors Must Report on at Least 1 Patient, 1 Measure for MACRA
FRIDAY, Dec. 15, 2017 (HealthDay News) -- In order to meet the 2017 Medicare and CHIP Reauthorization Act (MACRA) participation reporting deadline and avoid a Medicare payment penalty in 2019, physicians must report on at least one patient and one measure by Dec. 31, and submit to Medicare no later than Feb. 28, 2018, according to a report from the American Medical Association (AMA).
Making Insurers Participate in Marketplace Could Cut Volatility
THURSDAY, Dec. 14, 2017 (HealthDay News) -- Requiring insurers that participate in Medicare or Medicaid to also participate in Marketplaces in the same geographic area could improve access to insurance, according to a study published in the December issue of Health Affairs.
Recent Change in Spectrum of HIV-Linked Kidney Disease
THURSDAY, Dec. 14, 2017 (HealthDay News) -- The spectrum of HIV-associated kidney disease has changed with the improvement of therapy for HIV infection, according to a review article published in the Dec. 14 issue of the New England Journal of Medicine.
Deceleration in Health Care Spending Growth in 2016
MONDAY, Dec. 11, 2017 (HealthDay News) -- Health care spending growth slowed in 2016 following faster growth in 2014 and 2015, according to research published online Dec. 6 in Health Affairs.
CVS-Aetna Merger Has Implications for Doctors' Offices
TUESDAY, Dec. 5, 2017 (HealthDay News) -- CVS Health's planned purchase of insurance giant Aetna, a $69 billion deal, was announced Sunday.
Nivolumab May Induce Successful Depletion of HIV Reservoir
MONDAY, Dec. 4, 2017 (HealthDay News) -- Nivolumab treatment for non-small-cell lung cancer may induce successful depletion of HIV reservoir, according to a letter to the editor published online Dec. 1 in the Annals of Oncology.